2-[6,9-bis[1-carboxy-4-(2,3-dihydroxypropylamino)-4-oxobutyl]-3,6,9,15-tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-3-yl]-8,9-dihydroxy-5-oxononanoic acid;2-[6,9-bis[1-carboxy-4-[[3-hydroxy-2-(hydroxymethyl)propanoyl]amino]butyl]-3,6,9,15-tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-3-yl]-9-hydroxy-8-(hydroxymethyl)-7-oxononanoic acid
C75H122N12O30 — CID 158018898
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[6,9-bis[1-carboxy-4-(2,3-dihydroxypropylamino)-4-oxobutyl]-3,6,9,15-tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-3-yl]-8,9-dihydroxy-5-oxononanoic acid;2-[6,9-bis[1-carboxy-4-[[3-hydroxy-2-(hydroxymethyl)propanoyl]amino]butyl]-3,6,9,15-tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-3-yl]-9-hydroxy-8-(hydroxymethyl)-7-oxononanoic acid
2-[6,9-bis[1-carboxy-4-(2,3-dihydroxypropylamino)-4-oxobutyl]-3,6,9,15-tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-3-yl]-8,9-dihydroxy-5-oxononanoic acid;2-[6,9-bis[1-carboxy-4-[[3-hydroxy-2-(hydroxymethyl)propanoyl]amino]butyl]-3,6,9,15-tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-3-yl]-9-hydroxy-8-(hydroxymethyl)-7-oxononanoic acid (PubChem CID 158018898) has the molecular formula C75H122N12O30 and a molecular weight of 1671.85 g/mol. Its IUPAC name is 2-[6,9-bis[1-carboxy-4-(2,3-dihydroxypropylamino)-4-oxobutyl]-3,6,9,15-tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-3-yl]-8,9-dihydroxy-5-oxononanoic acid;2-[6,9-bis[1-carboxy-4-[[3-hydroxy-2-(hydroxymethyl)propanoyl]amino]butyl]-3,6,9,15-tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-3-yl]-9-hydroxy-8-(hydroxymethyl)-7-oxononanoic acid.
Molecular Properties
| Compound Name | 2-[6,9-bis[1-carboxy-4-(2,3-dihydroxypropylamino)-4-oxobutyl]-3,6,9,15-tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-3-yl]-8,9-dihydroxy-5-oxononanoic acid;2-[6,9-bis[1-carboxy-4-[[3-hydroxy-2-(hydroxymethyl)propanoyl]amino]butyl]-3,6,9,15-tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-3-yl]-9-hydroxy-8-(hydroxymethyl)-7-oxononanoic acid |
|---|---|
| PubChem CID | 158018898 |
| Molecular Formula | C75H122N12O30 |
| Molecular Weight | 1671.85 g/mol |
| Exact Mass | 1670.84 |
| IUPAC Name | 2-[6,9-bis[1-carboxy-4-(2,3-dihydroxypropylamino)-4-oxobutyl]-3,6,9,15-tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-3-yl]-8,9-dihydroxy-5-oxononanoic acid;2-[6,9-bis[1-carboxy-4-[[3-hydroxy-2-(hydroxymethyl)propanoyl]amino]butyl]-3,6,9,15-tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-3-yl]-9-hydroxy-8-(hydroxymethyl)-7-oxononanoic acid |
| SMILES | O=C(CCC(O)CO)CCC(C(=O)O)N1CCN(C(CCC(=O)NCC(O)CO)C(=O)O)CCN(C(CCC(=O)NCC(O)CO)C(=O)O)Cc2cccc(n2)C1.O=C(CCCCC(C(=O)O)N1CCN(C(CCCNC(=O)C(CO)CO)C(=O)O)CCN(C(CCCNC(=O)C(CO)CO)C(=O)O)Cc2cccc(n2)C1)C(CO)CO |
| InChI | InChI=1S/C39H64N6O15.C36H58N6O15/c46-20-26(21-47)34(52)11-2-1-8-32(38(57)58)44-16-14-43(31(37(55)56)9-4-12-40-35(53)27(22-48)23-49)15-17-45(19-30-7-3-6-29(18-44)42-30)33(39(59)60)10-5-13-41-36(54)28(24-50)25-51;43-20-26(47)5-4-25(46)6-7-30(35(54)55)41-14-12-40(29(34(52)53)8-10-32(50)37-16-27(48)21-44)13-15-42(19-24-3-1-2-23(18-41)39-24)31(36(56)57)9-11-33(51)38-17-28(49)22-45/h3,6-7,26-28,31-33,46-51H,1-2,4-5,8-25H2,(H,40,53)(H,41,54)(H,55,56)(H,57,58)(H,59,60);1-3,26-31,43-45,47-49H,4-22H2,(H,37,50)(H,38,51)(H,52,53)(H,54,55)(H,56,57) |
| InChIKey | FFUYRAHUTLHJAH-UHFFFAOYSA-N |
| XLogP | -6.57 |
| TPSA | 662.32 Ų |
| H-Bond Donors | 22 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 53 |
| Heavy Atoms | 117 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1671.85 |
| LogP ≤ 5 | -6.57 |
| H-Bond Donors ≤ 5 | 22 |
| H-Bond Acceptors ≤ 10 | 32 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158018898 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.